231 related articles for article (PubMed ID: 26910040)
1. A control strategy to investigate the relationship between specific productivity and high-mannose glycoforms in CHO cells.
Zalai D; Hevér H; Lovász K; Molnár D; Wechselberger P; Hofer A; Párta L; Putics Á; Herwig C
Appl Microbiol Biotechnol; 2016 Aug; 100(16):7011-24. PubMed ID: 26910040
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the interactions of critical scale-up parameters (pH, pO
Brunner M; Fricke J; Kroll P; Herwig C
Bioprocess Biosyst Eng; 2017 Feb; 40(2):251-263. PubMed ID: 27752770
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the understanding of biological implications and modulation methodologies of monoclonal antibody N-linked high mannose glycans.
Shi HH; Goudar CT
Biotechnol Bioeng; 2014 Oct; 111(10):1907-19. PubMed ID: 24975601
[TBL] [Abstract][Full Text] [Related]
4. Monensin, a small molecule ionophore, can be used to increase high mannose levels on monoclonal antibodies generated by Chinese hamster ovary production cell-lines.
Pande S; Rahardjo A; Livingston B; Mujacic M
Biotechnol Bioeng; 2015 Jul; 112(7):1383-94. PubMed ID: 25619381
[TBL] [Abstract][Full Text] [Related]
5. Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures.
Chee Furng Wong D; Tin Kam Wong K; Tang Goh L; Kiat Heng C; Gek Sim Yap M
Biotechnol Bioeng; 2005 Jan; 89(2):164-77. PubMed ID: 15593097
[TBL] [Abstract][Full Text] [Related]
6. An efficient method to control high mannose and core fucose levels in glycosylated antibody production using deoxymannojirimycin.
Shalel Levanon S; Aharonovitz O; Maor-Shoshani A; Abraham G; Kenett D; Aloni Y
J Biotechnol; 2018 Jun; 276-277():54-62. PubMed ID: 29673624
[TBL] [Abstract][Full Text] [Related]
7. Cell culture media supplemented with raffinose reproducibly enhances high mannose glycan formation.
Brühlmann D; Muhr A; Parker R; Vuillemin T; Bucsella B; Kalman F; Torre S; La Neve F; Lembo A; Haas T; Sauer M; Souquet J; Broly H; Hemberger J; Jordan M
J Biotechnol; 2017 Jun; 252():32-42. PubMed ID: 28465212
[TBL] [Abstract][Full Text] [Related]
8. Process performance and product quality in an integrated continuous antibody production process.
Karst DJ; Steinebach F; Soos M; Morbidelli M
Biotechnol Bioeng; 2017 Feb; 114(2):298-307. PubMed ID: 27497430
[TBL] [Abstract][Full Text] [Related]
9. Modulation of high mannose levels in N-linked glycosylation through cell culture process conditions to increase antibody-dependent cell-mediated cytotoxicity activity for an antibody biosimilar.
Rameez S; Gowtham YK; Nayar G; Mostafa SS
Biotechnol Prog; 2021 Sep; 37(5):e3176. PubMed ID: 34021724
[TBL] [Abstract][Full Text] [Related]
10. An empirical modeling platform to evaluate the relative control discrete CHO cell synthetic processes exert over recombinant monoclonal antibody production process titer.
McLeod J; O'Callaghan PM; Pybus LP; Wilkinson SJ; Root T; Racher AJ; James DC
Biotechnol Bioeng; 2011 Sep; 108(9):2193-204. PubMed ID: 21445882
[TBL] [Abstract][Full Text] [Related]
11. Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.
Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
Biotechnol Bioeng; 2006 Aug; 94(6):1033-44. PubMed ID: 16736530
[TBL] [Abstract][Full Text] [Related]
12. S-Sulfocysteine simplifies fed-batch processes and increases the CHO specific productivity via anti-oxidant activity.
Hecklau C; Pering S; Seibel R; Schnellbaecher A; Wehsling M; Eichhorn T; Hagen Jv; Zimmer A
J Biotechnol; 2016 Jan; 218():53-63. PubMed ID: 26654938
[TBL] [Abstract][Full Text] [Related]
13. Glycoprofiling effects of media additives on IgG produced by CHO cells in fed-batch bioreactors.
Kildegaard HF; Fan Y; Sen JW; Larsen B; Andersen MR
Biotechnol Bioeng; 2016 Feb; 113(2):359-66. PubMed ID: 26222761
[TBL] [Abstract][Full Text] [Related]
14. A class of low-cost alternatives to kifunensine for increasing high mannose N-linked glycosylation for monoclonal antibody production in Chinese hamster ovary cells.
Brantley TJ; Mitchelson FG; Khattak SF
Biotechnol Prog; 2021 Jan; 37(1):e3076. PubMed ID: 32888259
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics profiling of a CHO cell culture system unravels the effect of culture pH on cell growth, antibody titer, and product quality.
Lee AP; Kok YJ; Lakshmanan M; Leong D; Zheng L; Lim HL; Chen S; Mak SY; Ang KS; Templeton N; Salim T; Wei X; Gifford E; Tan AH; Bi X; Ng SK; Lee DY; Ling WLW; Ho YS
Biotechnol Bioeng; 2021 Nov; 118(11):4305-4316. PubMed ID: 34289087
[TBL] [Abstract][Full Text] [Related]
16. Optimization of cultivation conditions in spin tubes for Chinese hamster ovary cells producing erythropoietin and the comparison of glycosylation patterns in different cultivation vessels.
Strnad J; Brinc M; Spudić V; Jelnikar N; Mirnik L; Carman B; Kravanja Z
Biotechnol Prog; 2010; 26(3):653-63. PubMed ID: 20544713
[TBL] [Abstract][Full Text] [Related]
17. Mannose metabolism in recombinant CHO cells and its effect on IgG glycosylation.
Slade PG; Caspary RG; Nargund S; Huang CJ
Biotechnol Bioeng; 2016 Jul; 113(7):1468-80. PubMed ID: 26724786
[TBL] [Abstract][Full Text] [Related]
18. Use of a small molecule cell cycle inhibitor to control cell growth and improve specific productivity and product quality of recombinant proteins in CHO cell cultures.
Du Z; Treiber D; McCarter JD; Fomina-Yadlin D; Saleem RA; McCoy RE; Zhang Y; Tharmalingam T; Leith M; Follstad BD; Dell B; Grisim B; Zupke C; Heath C; Morris AE; Reddy P
Biotechnol Bioeng; 2015 Jan; 112(1):141-55. PubMed ID: 25042542
[TBL] [Abstract][Full Text] [Related]
19. Synchronized mammalian cell culture: part I--a physical strategy for synchronized cultivation under physiological conditions.
Barradas OP; Jandt U; Becker M; Bahnemann J; Pörtner R; Zeng AP
Biotechnol Prog; 2015; 31(1):165-74. PubMed ID: 25044769
[TBL] [Abstract][Full Text] [Related]
20. Manganese increases high mannose glycoform on monoclonal antibody expressed in CHO when glucose is absent or limiting: Implications for use of alternate sugars.
Surve T; Gadgil M
Biotechnol Prog; 2015; 31(2):460-7. PubMed ID: 25504679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
